ELI LILLY & Co is 664.7x more valuable than Tyra Biosciences, Inc. by market capitalization ($1.067 T vs $1.61 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | TYRA | LLY |
|---|---|---|
| Market cap | $1.61 B | $1.067 T |
| US-listed rank | #2292 | #11 |
| Revenue (latest FY) | - | $65.18B |
| Net income (latest FY) | -$119.95M | $20.64B |
| Net margin | - | 31.7% |
| P/E (trailing FY) | - | 51.7 |
| SEC filings | 396 | 989 |
ELI LILLY & Co is 664.7x more valuable than Tyra Biosciences, Inc. by market capitalization ($1.067 T vs $1.61 B).
Full pages: Tyra Biosciences, Inc. and ELI LILLY & Co, or browse the full rankings.